Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Reiss

Showing results (11-20 of 509) with videos related to

Pageof 51
Sort By:
The Lancet. HIV|April 3, 2025
Pitavastatin not so pleiotropic in people with HIV?Peter Reiss, Peter Hunt
Small (Weinheim an Der Bergstrasse, Germany)|February 8, 2007
Highly luminescent Cd1-xZnxSe/ZnS core/shell nanocrystals emitting in the blue-green spectral rangeMyriam Protière, Peter Reiss
Current Infectious Disease Reports|July 18, 2003
When to Start Antiretroviral Therapy and What to Start With-- A European PerspectiveFerdinand W.N.M. Wit, Peter Reiss
Antiviral Therapy|October 14, 2014
Working together to provide generics for healthEduard J Beck, Peter Reiss
AIDS (London, England)|May 5, 2017
Epidemiology of ageing with HIV: what can we learn from cohorts?Caroline A Sabin, Peter Reiss
The Journal of Infectious Diseases|December 19, 2017
Noncommunicable Diseases in People Living With HIV: Time for Integrated CareMarc van der Valk, Peter Reiss
Small (Weinheim an Der Bergstrasse, Germany)|January 21, 2009
Core/Shell semiconductor nanocrystalsPeter Reiss, Myriam Protière, Liang Li
Current Opinion in HIV and AIDS|April 18, 2009
Drug interactions between statins and antiretroviral agentsDavid Burger, Erik Stroes, Peter Reiss
Current Opinion in Infectious Diseases|December 10, 2009
Abacavir and cardiovascular riskGeorg M N Behrens, Peter Reiss
Current Opinion in Infectious Diseases|June 25, 2003
Lipid profiles associated with antiretroviral drug choicesMarc van der Valk, Peter Reiss
Pageof 51

Showing results (11-20 of 509) with videos related to

Sort By:
Pageof 51
The Lancet. HIV|April 3, 2025
Pitavastatin not so pleiotropic in people with HIV?Peter Reiss, Peter Hunt
Small (Weinheim an Der Bergstrasse, Germany)|February 8, 2007
Highly luminescent Cd1-xZnxSe/ZnS core/shell nanocrystals emitting in the blue-green spectral rangeMyriam Protière, Peter Reiss
Current Infectious Disease Reports|July 18, 2003
When to Start Antiretroviral Therapy and What to Start With-- A European PerspectiveFerdinand W.N.M. Wit, Peter Reiss
Antiviral Therapy|October 14, 2014
Working together to provide generics for healthEduard J Beck, Peter Reiss
AIDS (London, England)|May 5, 2017
Epidemiology of ageing with HIV: what can we learn from cohorts?Caroline A Sabin, Peter Reiss
The Journal of Infectious Diseases|December 19, 2017
Noncommunicable Diseases in People Living With HIV: Time for Integrated CareMarc van der Valk, Peter Reiss
Small (Weinheim an Der Bergstrasse, Germany)|January 21, 2009
Core/Shell semiconductor nanocrystalsPeter Reiss, Myriam Protière, Liang Li
Current Opinion in HIV and AIDS|April 18, 2009
Drug interactions between statins and antiretroviral agentsDavid Burger, Erik Stroes, Peter Reiss
Current Opinion in Infectious Diseases|December 10, 2009
Abacavir and cardiovascular riskGeorg M N Behrens, Peter Reiss
Current Opinion in Infectious Diseases|June 25, 2003
Lipid profiles associated with antiretroviral drug choicesMarc van der Valk, Peter Reiss
Pageof 51